Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests

Abstract Background Cytokines, chemokines, adipocytokines, soluble cell receptors, and immune activation markers play an important role in immune responsiveness and can provide prognostic value since they reflect underlying conditions and disease states. This study was undertaken to investigate the...

Full description

Bibliographic Details
Main Authors: Najib Aziz, Roger Detels, Joshua J. Quint, David Gjertson, Timothy Ryner, Anthony W. Butch
Format: Article
Language:English
Published: BMC 2019-09-01
Series:BMC Immunology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12865-019-0313-0
id doaj-c11891e197b04f64a17be08450a9cc62
record_format Article
spelling doaj-c11891e197b04f64a17be08450a9cc622020-11-25T03:00:26ZengBMCBMC Immunology1471-21722019-09-0120111110.1186/s12865-019-0313-0Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker testsNajib Aziz0Roger Detels1Joshua J. Quint2David Gjertson3Timothy Ryner4Anthony W. Butch5Department of Epidemiology, Fielding School of Public Health at University California Los Angeles (UCLA)Department of Epidemiology, Fielding School of Public Health at University California Los Angeles (UCLA)Department of Epidemiology, Fielding School of Public Health at University California Los Angeles (UCLA)Department of Biostatics, Fielding School of Public Health, UCLADepartment of Epidemiology, Fielding School of Public Health at University California Los Angeles (UCLA)Department of Intercollegiate Athletes, UCLAAbstract Background Cytokines, chemokines, adipocytokines, soluble cell receptors, and immune activation markers play an important role in immune responsiveness and can provide prognostic value since they reflect underlying conditions and disease states. This study was undertaken to investigate the components of biological variation for various laboratory tests of blood immunological biomarkers. Results Estimates of intra-individual coefficient of variation (CVI) and inter-individual coefficient of variation (CVG) were examined for blood immunological biomarkers. Biomarkers with CVI < 10% for both genders were CD3, CD4, and CD8 T-cells, serum levels of soluble cluster of differentiation 14 (sCD14), sCD163, and soluble glycoprotein 130 (sgp130). The CVI for serum levels of adiponectin, interleukin-1 receptor antagonist (IL-1Ra), macrophage inflammatory protein 1 beta (MIP-1β), soluble CD40 Ligand (sCD40L), soluble interleukin-2 receptor alpha (sIL-2Rα), soluble interleukin-6 receptor (sIL-6R), soluble tumor necrosis factor receptor II (sTNF-RII), and tumor necrosis factor alpha (TNF-α) were between 11 and 20%. Biomarkers with CVG < 20% were CD3 T-cell, and serum concentrations of sCD14, sCD40L, and sgp130. The biomarkers with CVG > 40% were adiponectin, IL-1ra, leptin, MIP-1β, sCD163, and sIL-2Rα. Conclusion The biological variations of biomarkers have important monitoring value for longitudinal investigation and are essential for quality specification of tests that are performed in the laboratory. The CVI was relatively small while CVG was comparatively large and mean values of each biomarker vary between subjects. The individuality of biomarkers significantly influences reference interval values. A majority of the biomarkers in this study had strong individuality and the result of each biomarker should be cautiously interpreted if using established reference interval values. Comparison of a patient’s test result with previous ones may be more useful than the usage of conventional reference values.http://link.springer.com/article/10.1186/s12865-019-0313-0ChemokineCytokinesImmune activationInterleukinSoluble markers
collection DOAJ
language English
format Article
sources DOAJ
author Najib Aziz
Roger Detels
Joshua J. Quint
David Gjertson
Timothy Ryner
Anthony W. Butch
spellingShingle Najib Aziz
Roger Detels
Joshua J. Quint
David Gjertson
Timothy Ryner
Anthony W. Butch
Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests
BMC Immunology
Chemokine
Cytokines
Immune activation
Interleukin
Soluble markers
author_facet Najib Aziz
Roger Detels
Joshua J. Quint
David Gjertson
Timothy Ryner
Anthony W. Butch
author_sort Najib Aziz
title Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests
title_short Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests
title_full Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests
title_fullStr Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests
title_full_unstemmed Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests
title_sort biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests
publisher BMC
series BMC Immunology
issn 1471-2172
publishDate 2019-09-01
description Abstract Background Cytokines, chemokines, adipocytokines, soluble cell receptors, and immune activation markers play an important role in immune responsiveness and can provide prognostic value since they reflect underlying conditions and disease states. This study was undertaken to investigate the components of biological variation for various laboratory tests of blood immunological biomarkers. Results Estimates of intra-individual coefficient of variation (CVI) and inter-individual coefficient of variation (CVG) were examined for blood immunological biomarkers. Biomarkers with CVI < 10% for both genders were CD3, CD4, and CD8 T-cells, serum levels of soluble cluster of differentiation 14 (sCD14), sCD163, and soluble glycoprotein 130 (sgp130). The CVI for serum levels of adiponectin, interleukin-1 receptor antagonist (IL-1Ra), macrophage inflammatory protein 1 beta (MIP-1β), soluble CD40 Ligand (sCD40L), soluble interleukin-2 receptor alpha (sIL-2Rα), soluble interleukin-6 receptor (sIL-6R), soluble tumor necrosis factor receptor II (sTNF-RII), and tumor necrosis factor alpha (TNF-α) were between 11 and 20%. Biomarkers with CVG < 20% were CD3 T-cell, and serum concentrations of sCD14, sCD40L, and sgp130. The biomarkers with CVG > 40% were adiponectin, IL-1ra, leptin, MIP-1β, sCD163, and sIL-2Rα. Conclusion The biological variations of biomarkers have important monitoring value for longitudinal investigation and are essential for quality specification of tests that are performed in the laboratory. The CVI was relatively small while CVG was comparatively large and mean values of each biomarker vary between subjects. The individuality of biomarkers significantly influences reference interval values. A majority of the biomarkers in this study had strong individuality and the result of each biomarker should be cautiously interpreted if using established reference interval values. Comparison of a patient’s test result with previous ones may be more useful than the usage of conventional reference values.
topic Chemokine
Cytokines
Immune activation
Interleukin
Soluble markers
url http://link.springer.com/article/10.1186/s12865-019-0313-0
work_keys_str_mv AT najibaziz biologicalvariationofimmunologicalbloodbiomarkersinhealthyindividualsandqualitygoalsforbiomarkertests
AT rogerdetels biologicalvariationofimmunologicalbloodbiomarkersinhealthyindividualsandqualitygoalsforbiomarkertests
AT joshuajquint biologicalvariationofimmunologicalbloodbiomarkersinhealthyindividualsandqualitygoalsforbiomarkertests
AT davidgjertson biologicalvariationofimmunologicalbloodbiomarkersinhealthyindividualsandqualitygoalsforbiomarkertests
AT timothyryner biologicalvariationofimmunologicalbloodbiomarkersinhealthyindividualsandqualitygoalsforbiomarkertests
AT anthonywbutch biologicalvariationofimmunologicalbloodbiomarkersinhealthyindividualsandqualitygoalsforbiomarkertests
_version_ 1724698182778093568